St. Petersburg Institute of Bioregulation and Gerontology was established in 1992 and has been engaged in research in bioregulation and gerontology. Its basic task is to introduce into the medical practice the results of 20-year experimental and clinical studies of a new class of medicinal substances – peptide bioregulators, which were created in the Research Laboratory of Bioregulators of the S.M. Kirov Military Medical Academy.
On the basis of peptide bioregulators, for the first time in world medical practice, a new medical technology - bioregulation therapy has been developed. Currently it is successfully used to restore and preserve the main functions of organs and tissues of the body within the genetically determined human lifespan (100-110 years). A method of complex prevention of age-related pathology, aimed at slowing down the aging process and increasing average life expectancy to the upper species limit has been developed.
The uniqueness of peptide bioregulators lies in the combination of high efficiency and absence of chemical foreignness for the organism. There is currently no alternative to peptide bioregulators in gerontology. Peptide bioregulators are used in individual programs for the prevention of genetically determined, environmentally and professionally caused diseases and have no analogues in world practice.
Long-term fundamental scientific and clinical studies have shown high efficacy of using peptide bioregulators to restore the adaptive mechanisms of the body, normalize metabolic processes in organs and tissues, which contribute to prevention of accelerated ageing and age-related pathology.
Main areas of research activities of the St. Petersburg Institute of Bioregulation and Gerontology:
- fundamental studies, improvement of methods for diagnosis and prognosis of various diseases, development of research and production programmes in bioregulation and gerontology;
- design, clinical study, manufacture and introduction into the clinical practice of medications, state-of-the-art technologies of diagnostics and therapy for the purpose of early diagnostics, prevention and treatment of age-related pathologies;
- study of the human genotype in order to improve methods for diagnosing, predicting and treating age-related pathology;
- study of markers of intravital diagnosis of neurodegenerative diseases;
- study of demographic aspects of population aging;
- propagation of research findings in the field of bioregulation and gerontology (by organizing scientific conferences, publishing research papers etc.)
Results of research activities
- The concept of peptide regulation of ageing has been developed.
- A scientific school on Biogerontology has been created (more than 150 doctoral and master's theses have been prepared and defended, more than 1200 publications have been issued, comprising of 56 monographs; 61 textbooks, scientific publications, manuals, teaching aids, chapters in monographs; more than 400 - articles in foreign and domestic journals, more than 700 - abstracts of reports at congresses, conferences and symposiums in Russia and abroad.
- The Program "Prevention of age-related pathology and accelerated ageing, reduction of premature mortality from biological causes, and extension of the working period the population of Russia" has been developed. It was approved by various government departments and committees. The Program was reviewed and recommended for implementation by the Commission on the formation of a healthy lifestyle of the Civic Chamber of the Russian Federation and the UN Department for Research on Ageing.
- Since 1996, the Bulletin of the Gerontological Society of the Russian Academy of Sciences has been published. It reflects all the main scientific, organizational and social events in Gerontology and Geriatrics in Russia and abroad (more than 130 issues have been published in total).
- Since 1997, the first Russian gerontological peer-reviewed journal "Advances in Gerontology" has been published (the editorial board includes the world's leading gerontologists and scientists from the Russian Academy of Sciences, Russian Academy of Medical Sciences and other departments), which publishes works from many countries (30 issues in total). This journal is included in the list recommended by the State Commission for Academic Degrees and Titles for the publication of materials for doctoral dissertations, and in 2009 the journal took the 2nd place in Russia in terms of citation among all scientific medical journals. Since 2011, the Springer Verlag publishing house has been publishing the journal in English due to its high scientific rating.